Oisin Biotechnologies
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Overview
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Oisin Biotechnologies has raised a total of $5m in funding over 4 rounds.
Key Insights:
- Oisin Biotechnologies Seed round, May 2021: $5m
- Oisin Biotechnologies Venture Funding Round June 2020: $2.1m
Oisin Biotechnologies Seed round, May 2021
$5m
Oisin Biotechnologies Venture Funding Round June 2020
$2.1m
Industries
Oisin Biotechnologies is active in the following industries: